Related references
Note: Only part of the references are listed.Elucidating the Molecular Basis of Avibactam-Mediated Inhibition of Class A β-Lactamases
Chandan Kumar Das et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases
Stephen A. Cochrane et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options
Ann A. Elshamy et al.
FUTURE SCIENCE OA (2020)
Faropenem Susceptibility of Multidrug-resistant Contemporary Clinical Isolates from Zhejiang Province, China
Xue-Wen Feng et al.
INFECTIOUS MICROBES & DISEASES (2020)
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Nicholas A. Turner et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
Xiaokui Huo et al.
ACTA PHARMACEUTICA SINICA B (2019)
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections
Laura McEntee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Catherine L. Tooke et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults
Tobias Welte et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop
Antonela R. Palacios et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Tebipenem, the first oral carbapenem antibiotic
Akash Jain et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Penicillin minor determinants History and relevance for current diagnosis
N. Franklin Adkinson et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
Anou M. Somboro et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Recent updates of carbapenem antibiotics
Mohammed I. El-Gamal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cefepime-induced neurotoxicity: a systematic review
Lauren E. Payne et al.
CRITICAL CARE (2017)
Inhibitors of metallo-β-lactamases
Caitlyn M. Rotondo et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
A Livestock-Associated, Multidrug-Resistant, Methicillin-Resistant Staphylococcus aureus Clonal Complex 97 Lineage Spreading in Dairy Cattle and Pigs in Italy
Fabiola Feltrin et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Class D β-lactamases do exist in Gram-positive bacteria
Marta Toth et al.
NATURE CHEMICAL BIOLOGY (2016)
Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides
Nermina Malanovic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
A review of the pharmacokinetics and pharmacodynamics of aztreonam
Christopher Ramsey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
Douglas J. Biedenbach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins
Francesco Gaeta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The -Lactams Strike Back: Ceftazidime-Avibactam
Evan J. Zasowski et al.
PHARMACOTHERAPY (2015)
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Sarah M. Drawz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance
S. D. Lahiri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Ceftaroline Fosamil: A Brief Clinical Review
Debbie-Ann T. Shirley et al.
INFECTIOUS DISEASES AND THERAPY (2013)
THE USE OF CEPHALOSPORINS IN PENICILLIN-ALLERGIC PATIENTS: A LITERATURE REVIEW
James D. Campagna et al.
JOURNAL OF EMERGENCY MEDICINE (2012)
From the regulation of peptidoglycan synthesis to bacterial growth and morphology
Athanasios Typas et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Recent Advances in Stability Studies of Carbapenems
Judyta Cielecka-Piontek et al.
CURRENT PHARMACEUTICAL ANALYSIS (2011)
Beta-lactam antibiotics: from antibiosis to resistance and bacteriology
Kok-Fai Kong et al.
APMIS (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Characteristics of doripenem: a new broad-spectrum antibiotic
Francisco Alvarez-Lerma
Drug Design Development and Therapy (2010)
Protein Engineering of Penicillin Acylase
V. I. Tishkov et al.
ACTA NATURAE (2010)
Antianaerobic Activity of Sulopenem Compared to Six Other Agents
Lois M. Ednie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Computational study on decarboxylation mechanism of β-lactamases inhibitors: Clavulanate vs. sulbactam
Rui Li et al.
CHEMICAL PHYSICS LETTERS (2009)
Ceftaroline A Novel Broad-Spectrum Cephalosporin with Activity against Meticillin-Resistant Staphylococcus aureus
George G. Zhanel et al.
DRUGS (2009)
Waves of resistance: Staphylococcus aureus in the antibiotic era
Henry F. Chambers et al.
NATURE REVIEWS MICROBIOLOGY (2009)
The Mechanisms of Catalysis by Metallo -Lactamases
Michael I. Page et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2008)
Pharmacokinetics. and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity
Bindu Murthy et al.
CLINICAL PHARMACOKINETICS (2008)
Cephalosporin use in treatment of patients with penicillin allergies
Daryl D. DePestel et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2008)
Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria
Jean-Luc Mainardi et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Efficacy and safety of cefepime: a systematic review and meta-analysis
Dafna Yahav et al.
LANCET INFECTIOUS DISEASES (2007)
Faropelnem: review of a new oral penem
Kristen N. Schurek et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Assessing the protonation state of drug molecules:: The case of aztreonam
Natalia Diaz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Catalytic mechanism of class B2 metallo-β-lactamase
DG Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations
JD Buynak
BIOCHEMICAL PHARMACOLOGY (2006)
Immediate allergic reactions to cephalosporins:: Evaluation of cross-reactivity with a panel of penicillins and cephalosporins
C Antunez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes
Pauline Macheboeuf et al.
FEMS MICROBIOLOGY REVIEWS (2006)
β-Lactam resistance in Staphylococcus aureus:: the adaptive resistance of a plastic genome
CCS Fuda et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
β-lactam antibiotic resistance:: a current structural perspective
MS Wilke et al.
CURRENT OPINION IN MICROBIOLOGY (2005)
Bacterial resistance to β-lactam antibiotics:: Compelling opportunism, compelling opportunity
JF Fisher et al.
CHEMICAL REVIEWS (2005)
Bioisosterism: A useful strategy for molecular modification and drug design
LMA Lima et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers
A Schmitt-Hoffmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
A review of the antimicrobial activity of clavulanate
J Finlay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The art of fusion: From penams and cephems to penems
A Dalhoff et al.
CHEMOTHERAPY (2003)
Chemical and microbiologic aspects of penems, a distinct class of beta-lactams: Focus on faropenem
JMT Hamilton-Miller
PHARMACOTHERAPY (2003)
Ertapenem - A review of its use in the management of bacterial infections
MP Curran et al.
DRUGS (2003)
Method for estimation of low outer membrane permeability to β-lactam antibiotics
B Lakaye et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Molecular analysis of beta-lactamase structure and function
FK Majiduddin et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2002)
Faropenem daloxate - Penem antibiotic
LA Sorbera et al.
DRUGS OF THE FUTURE (2002)
Outer membrane channels and active transporters for the uptake of antibiotics
V Braun et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Carbapenemases: a problem in waiting?
DM Livermore et al.
CURRENT OPINION IN MICROBIOLOGY (2000)
β-lactamase epidemiology and the utility of established and novel β-lactamase inhibitors
DJ Payne et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Meropenem - A review of its use in patients in intensive care
M Hurst et al.
DRUGS (2000)
Share Paper
